We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

bioMérieux

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App




System for Identification of Filamentous Fungi Evaluated

By LabMedica International staff writers
Posted on 27 Dec 2017
The utilization of matrix-assisted laser desorption/ionization – time of flight (MALDI-TOF) mass spectrometry has the potential to speed up and improve the accuracy of identification of filamentous fungi.

Invasive fungal infections are an important cause of morbidity and mortality affecting primarily immunocompromised patients. More...
While fungal identification to the species level is critical to providing appropriate therapy, it can be slow, laborious, and often relies on subjective morphologic criteria.

A team of collaborating scientists led by those at the ARUP Laboratories (Salt Lake City, UT, USA) in a multi-center study used MALDI-TOF mass spectrometry, to evaluate the accuracy of the system in identifying 1,601 clinical mold isolates as compared to identification by DNA sequence analysis and supported by morphologic and phenotypic testing.

The team used the VITEK MS v3.0 system (bioMérieux, Marcy l'Etoile. France) to correctly identify 91% of 1,519 samples to the species level of isolates representing organisms in the v3.0 database. An additional 27 isolates (2%) were correctly identified to the genus level. Fifteen isolates were incorrectly identified, either due to a single incorrect identification or multiple identifications from different genera. In those cases, when a single identification was provided that was not correct, the misidentification was within the same genus. The VITEK MS v3.0 was unable to identify 91 (6%) isolates, despite repeat testing. These isolates were distributed among all the genera.

Jenna Rychert, PhD, a research and development scientist and lead author of the study, said, “While speed is commonly cited as a major advantage of MALDI methods in the bacterial ID space, this is less of a factor with molds. As clinicians still have to take the organism of interest through the culturing process. However, in cases where clinicians aren't able to make an identification based on their visual inspection of the organism's morphology, using MALDI could allow them to skip the various additional, and time-consuming, tests required to further evaluating the organism.”

Dr. Rychert added, “I think if you compare the performance of the Vitek MS to someone who is a trained mycologist who has been looking at cultures for 20 years, it's probably not a whole lot different. But if you compare it to a whole mycology laboratory that has everyone from someone who just got out of school to that 20-year veteran, it's going to give you a more accurate answer more of the time.” The study was published on November 27, 2017, in the Journal of Clinical Microbiology.


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.